Silicone Oil Approval In USA

21 November 1994

The US Food and Drug Administration has approved German-based Adatomed's silicone oil for use, in conjunction with surgery, in reattaching the retina in cases where surgery alone has failed. Adatomed is a division of Chiron Vision. In clinical studies of patients with complicated retinal detachment, the oil was successful in 60% to 75% of patients. Reattachment rates reaching 98% have been observed in people with AIDS-related cytomegalovirus retinitis. Meantime, Chiron's Aredia (pamidronate) iv bone resorption inhibitor has received approval from the FDA for a second indication of moderate to severe Paget's disease.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight